Counselling and adverse event management for patients with myelodysplastic syndromes undergoing azacitidine therapy: a practice standard for Canadian nurses | Aplastic Anemia & MDS International Foundation Return to top.
  1. Education
  2. Research Articles
  3. Counselling and adverse event management for patients with myelodysplastic syndromes undergoing azacitidine therapy: a practice standard for Canadian nurses

Counselling and adverse event management for patients with myelodysplastic syndromes undergoing azacitidine therapy: a practice standard for Canadian nurses

Journal Title: 
Can Oncol Nurs J
Primary Author: 
Murray C
Author(s): 
Murray C, Wereley A, Nixon S, Hua-Yung C, von Riedemann S, Kurtin S; Canadian Nurses Working Group on Azacitidine in MDS
Original Publication Date: 
Monday, October 1, 2012
Full Article on PubMed: 
https://www.ncbi.nlm.nih.gov/pubmed/23362656/
Bone Marrow Disease(s): 
  • myelodysplastic syndromes (MDS)
Share with addtoany.com.